Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hainan Yang

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Cancer|February 6, 2019
Oxidized Vitamin C (DHA) Overcomes Resistance to EGFR-targeted Therapy of Lung Cancer through Disturbing Energy HomeostasisMingtong Ye, Nengzhi Pang, Ting Wan, et al.
Frontiers in Oncology|August 18, 2022
<i>EGFR</i> amplification is a putative resistance mechanism for NSCLC-LM patients with TKI therapy and is associated with poor outcomeHainan Yang, Lei Wen, Chao Zhao, et al.
Current Cancer Drug Targets|September 8, 2025
Driver Genes and Genomic Instability Predict the Incidence and Outcome of Brain MetastasesHainan Yang, Weiping Hong, Jie Ding, et al.
Gland Surgery|April 14, 2023
Different biopsy techniques for different pancreas graft locations after homolateral simultaneous pancreas-kidney transplantationLei Zhang, Li Li, Yirui Zhang, et al.
Heliyon|June 19, 2025
Corrigendum to "TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases" [Heliyon Volume 10, Issue 16, August 2024, Article e36532]Tao Lin, Xusheng Tang, Wanli Yang, et al.
Heliyon|September 11, 2024
TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastasesTao Lin, Xusheng Tang, Wanli Yang, et al.
CJC Open|May 18, 2026
Distal Vessel Diameter and Antegrade Crossing Success in Chronic Total Occlusion Percutaneous Coronary InterventionNing Yin, Ping Wang, Yuan Shan, et al.
Acta Biomaterialia|March 2, 2019
Synthesis and assessment of drug-eluting microspheres for transcatheter arterial chemoembolizationLingran Du, Yugang Huang, Qiang Zhang, et al.
Biological Procedures Online|May 7, 2024
PMS2 amplification contributes brain metastasis from lung cancerJianing Chen, Congli Hu, Hainan Yang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 25, 2024
Different genetic profiles contribute to worse overall survival in patients with leptomeningeal metastases of non-small-cell lung cancerXusheng Tang, Xiaojuan Hu, Lin Yuan, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Cancer|February 6, 2019
Oxidized Vitamin C (DHA) Overcomes Resistance to EGFR-targeted Therapy of Lung Cancer through Disturbing Energy HomeostasisMingtong Ye, Nengzhi Pang, Ting Wan, et al.
Frontiers in Oncology|August 18, 2022
<i>EGFR</i> amplification is a putative resistance mechanism for NSCLC-LM patients with TKI therapy and is associated with poor outcomeHainan Yang, Lei Wen, Chao Zhao, et al.
Current Cancer Drug Targets|September 8, 2025
Driver Genes and Genomic Instability Predict the Incidence and Outcome of Brain MetastasesHainan Yang, Weiping Hong, Jie Ding, et al.
Gland Surgery|April 14, 2023
Different biopsy techniques for different pancreas graft locations after homolateral simultaneous pancreas-kidney transplantationLei Zhang, Li Li, Yirui Zhang, et al.
Heliyon|June 19, 2025
Corrigendum to "TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases" [Heliyon Volume 10, Issue 16, August 2024, Article e36532]Tao Lin, Xusheng Tang, Wanli Yang, et al.
Heliyon|September 11, 2024
TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastasesTao Lin, Xusheng Tang, Wanli Yang, et al.
CJC Open|May 18, 2026
Distal Vessel Diameter and Antegrade Crossing Success in Chronic Total Occlusion Percutaneous Coronary InterventionNing Yin, Ping Wang, Yuan Shan, et al.
Acta Biomaterialia|March 2, 2019
Synthesis and assessment of drug-eluting microspheres for transcatheter arterial chemoembolizationLingran Du, Yugang Huang, Qiang Zhang, et al.
Biological Procedures Online|May 7, 2024
PMS2 amplification contributes brain metastasis from lung cancerJianing Chen, Congli Hu, Hainan Yang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 25, 2024
Different genetic profiles contribute to worse overall survival in patients with leptomeningeal metastases of non-small-cell lung cancerXusheng Tang, Xiaojuan Hu, Lin Yuan, et al.
Pageof 5